Return to CG107 Overview

Hypertension in pregnancy: the management of hypertensive disorders during pregnancy [CG107]

Measuring the use of this guidance

Recommendation: 1.1.2

Section 1.1.2 contains 2 recommendations: 1.1.2 Antiplatelet agents 1.1.2.1 Advise women at high risk of pre-eclampsia to take 75 mg of aspirin* daily from 12 weeks until the birth of the baby. Women at high risk are those with any of the following: hypertensive disease during a previous pregnancy chronic kidney disease autoimmune disease such as systemic lupus erythematosis or antiphospholipid syndrome type 1 or type 2 diabetes chronic hypertension. 1.1.2.2 Advise women with more than one moderate risk factor for pre-eclampsia to take 75 mg of aspirin* daily from 12 weeks until the birth of the baby. Factors indicating moderate risk are: first pregnancy age 40 years or older pregnancy interval of more than 10 years body mass index (BMI) of 35 kg/m2 or more at first visit family history of pre-eclampsia multiple pregnancy.

What was measured: All pregnant women at increased risk of pre-eclampsia should be offered a prescription of 75 mg of aspirin (unless contraindicated) to take daily from 12 weeks until birth.
Data collection end: May 2011
92.9%
Number that met the criteria: 369 / 397
Area covered: National
Source: Meher, S. & Neilson, J.P. (2014) Survey of current clinical practice for prevention of pre-eclampsia in the UK Archives of Disease in Childhood Neonatal Edition. 97, pA42.


Recommendation: 1.1.2.1

Advise women at high risk of pre-eclampsia to take 75 mg of aspirin* daily from 12 weeks until the birth of the baby. Women at high risk are those with any of the following: hypertensive disease during a previous pregnancy chronic kidney disease autoimmune disease such as systemic lupus erythematosis or antiphospholipid syndrome type 1 or type 2 diabetes chronic hypertension.

What was measured: Proportion of all antenatal bookers eligible for low dose aspirin, who go on receive it.
Data collection end: January 2011
18%
Number that met the criteria: 14 / 77
Area covered: Local
Source: Boban, D., Ferguson, E., Farquharson, M. (2013) Low dose aspirin in pregnancy, Archives of disease in childhood, fetal and neonatal edition, Vol 98; A37


Recommendation: 1.1.2.2

Advise women with more than one moderate risk factor for pre-eclampsia to take 75 mg of aspirin* daily from 12 weeks until the birth of the baby. Factors indicating moderate risk are: first pregnancy age 40 years or older pregnancy interval of more than 10 years body mass index (BMI) of 35 kg/m2 or more at first visit family history of pre-eclampsia multiple pregnancy.

What was measured: Proportion of all antenatal bookers eligible for low dose aspirin, who go on receive it.
Data collection end: January 2011
18%
Number that met the criteria: 14 / 77
Area covered: Local
Source: Boban, D., Ferguson, E., Farquharson, M. (2013) Low dose aspirin in pregnancy, Archives of disease in childhood, fetal and neonatal edition, Vol 98; A37



 Return to CG107 Overview